NIRSEVIMAB

NIRSEVIMAB was reported 1793 times

NIRSEVIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTIBODY-DEPENDENT ENHANCEMENT 1 1.0000
1 BACTERIAL DACRYOCYSTITIS 1 0.5000
2 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 302 0.3862
3 CONGENITAL FIBROSARCOMA 1 0.3333
4 KAPOSIFORM HAEMANGIOENDOTHELIOMA 1 0.3333
5 METAPNEUMOVIRUS BRONCHIOLITIS 3 0.2727
6 RESPIRATORY SYNCYTIAL VIRUS IMMUNISATION 2 0.2000
7 ANTIVIRAL PROPHYLAXIS 2 0.1818
8 IMMATURE PLATELET FRACTION INCREASED 2 0.1667
9 RESPIRATORY SYNCYTIAL VIRUS BRONCHITIS 18 0.1324
10 VACCINATION ERROR 5 0.1282
11 PULMONARY VALVE THICKENING 1 0.1111
12 NASOGASTRIC OUTPUT ABNORMAL 1 0.1000
13 VACCINATION SITE VESICLES 2 0.0909
14 UNKNOWN SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0909
15 PARECHOVIRUS INFECTION 1 0.0909
16 REACTION TO PREVIOUS EXPOSURE TO ANY VACCINE 1 0.0769
17 VACCINATION SITE DISCOLOURATION 1 0.0769
18 HYPOTONIC-HYPORESPONSIVE EPISODE 6 0.0769
19 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 50 0.0711
20 HYPOKINESIA NEONATAL 2 0.0690
21 HEMICLONIC SEIZURE 1 0.0667
22 NON-EPILEPTIC PAROXYSMAL EVENT 1 0.0667
23 UMBILICAL GRANULOMA 1 0.0667
24 CHILDHOOD ASTHMA 2 0.0645
25 VIRAL TRACHEITIS 1 0.0625
26 BRIEF RESOLVED UNEXPLAINED EVENT 7 0.0530
27 ACCIDENTAL EXPOSURE TO PRODUCT BY ELDERLY PERSON 1 0.0526
28 OPHTHALMIA NEONATORUM 2 0.0526
29 AUSCULTATION 1 0.0455
30 BRONCHIOLITIS 157 0.0446
31 INFANT IRRITABILITY 4 0.0408
32 HAEMANGIOMA-THROMBOCYTOPENIA SYNDROME 1 0.0385
33 ADVERSE EVENT FOLLOWING IMMUNISATION 2 0.0357
34 HERPES SIMPLEX SEPSIS 1 0.0345
35 POLYMERASE CHAIN REACTION POSITIVE 12 0.0344
36 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 1 0.0323
37 POST VACCINATION SYNDROME 1 0.0323
38 HCOV-OC43 INFECTION 1 0.0323
39 NEONATAL DYSPNOEA 3 0.0316
40 STERILE PYURIA 2 0.0312
41 ACUTE HAEMORRHAGIC OEDEMA OF INFANCY 1 0.0303
42 VACCINATION SITE OEDEMA 1 0.0303
43 RASH NEONATAL 1 0.0303
44 RESPIRATORY SYNCYTIAL VIRUS INFECTION 251 0.0288
45 INFANTILE APNOEA 23 0.0282
46 H3N2 INFLUENZA 1 0.0278
47 FIBRIN D DIMER 1 0.0270
48 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 22 0.0261
49 FONTANELLE BULGING 3 0.0254
50 BLOOD SMEAR TEST ABNORMAL 2 0.0250
51 USE OF ACCESSORY RESPIRATORY MUSCLES 10 0.0242
52 OXYGEN THERAPY 35 0.0213
53 PERINATAL STROKE 1 0.0196
54 DOSE CALCULATION ERROR 11 0.0188
55 VACCINATION SITE INFLAMMATION 1 0.0175
56 ENTERAL NUTRITION 10 0.0172
57 FLAIL CHEST 1 0.0169
58 TONIC POSTURING 1 0.0164
59 DEPENDENCE ON OXYGEN THERAPY 8 0.0162
60 VACCINATION FAILURE 27 0.0162
61 TYMPANIC MEMBRANE HYPERAEMIA 1 0.0141
62 HYPOTHERMIA NEONATAL 2 0.0140
63 MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN 1 0.0139
64 OROPHARYNGEAL ERYTHEMA 2 0.0137
65 NEONATAL RESPIRATORY ARREST 2 0.0137
66 ACCELERATED IDIOVENTRICULAR RHYTHM 2 0.0135
67 SUDDEN INFANT DEATH SYNDROME 6 0.0122
68 NEONATAL HYPOXIA 10 0.0121
69 NEONATAL SEIZURE 3 0.0120
70 HUMAN BOCAVIRUS INFECTION 2 0.0106
71 MENINGOCOCCAL SEPSIS 2 0.0105
72 BRADYCARDIA NEONATAL 12 0.0095
73 CEREBRAL HAEMORRHAGE NEONATAL 2 0.0094
74 VACCINATION SITE ERYTHEMA 2 0.0093
75 HUMAN RHINOVIRUS TEST POSITIVE 3 0.0080
76 LOWER RESPIRATORY TRACT INFECTION VIRAL 4 0.0079
77 HAEMOPHILUS TEST POSITIVE 1 0.0078
78 VACCINATION SITE REACTION 1 0.0078
79 ESCHERICHIA PYELONEPHRITIS 2 0.0077
80 OPISTHOTONUS 6 0.0075
81 CARDIAC ARREST NEONATAL 1 0.0072
82 OMPHALITIS 2 0.0071
83 MYCOPLASMA TEST POSITIVE 1 0.0066
84 POST-TUSSIVE VOMITING 1 0.0061
85 VARICELLA VIRUS TEST POSITIVE 1 0.0059
86 VACCINATION SITE SWELLING 1 0.0058
87 ENTEROVIRUS TEST POSITIVE 1 0.0057
88 FEBRILE CONVULSION 7 0.0057
89 INFANTILE SPITTING UP 3 0.0057
90 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 34 0.0056
91 APNOEA 42 0.0054
92 CONTRAINDICATION TO VACCINATION 1 0.0052
93 IRREGULAR BREATHING 3 0.0051
94 BRONCHOPULMONARY DYSPLASIA 4 0.0050
95 RED BLOOD CELL TRANSFUSION 2 0.0049
96 NEONATAL TACHYPNOEA 2 0.0048
97 INFLUENZA A VIRUS TEST POSITIVE 2 0.0046
98 RHINITIS 37 0.0046
99 WRONG PRODUCT ADMINISTERED 31 0.0046
100 CATARRH 4 0.0044
101 NEONATAL RESPIRATORY DISTRESS 4 0.0042
102 WRONG SCHEDULE 4 0.0042
103 INFANTILE SPASMS 3 0.0041
104 ENTEROBACTER TEST POSITIVE 1 0.0041
105 GASTROINTESTINAL TUBE INSERTION 10 0.0040
106 METAPNEUMOVIRUS INFECTION 3 0.0038
107 PROLONGED EXPIRATION 1 0.0038
108 CROUP INFECTIOUS 3 0.0038
109 SUPERINFECTION BACTERIAL 3 0.0038
110 PALPABLE PURPURA 1 0.0036
111 MORAXELLA INFECTION 1 0.0036
112 PRODUCT SELECTION ERROR 4 0.0036
113 VITAL FUNCTIONS ABNORMAL 3 0.0035
114 CARDIO-RESPIRATORY DISTRESS 1 0.0035
115 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
116 GASTROENTERITIS ROTAVIRUS 1 0.0032
117 ALLERGY TO VACCINE 1 0.0032
118 INTUSSUSCEPTION 3 0.0031
119 CYANOSIS NEONATAL 2 0.0031
120 DUPLICATE THERAPY ERROR 1 0.0031
121 RHINOVIRUS INFECTION 12 0.0031
122 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 2 0.0030
123 LARYNGOMALACIA 1 0.0030
124 PROTHROMBIN LEVEL INCREASED 1 0.0029
125 IMMUNE THROMBOCYTOPENIA 13 0.0028
126 PRODUCT DOSE CONFUSION 1 0.0028
127 IMMUNISATION REACTION 2 0.0028
128 MENINGITIS PNEUMOCOCCAL 1 0.0027
129 LIVIDITY 1 0.0027
130 HYPOTONIA NEONATAL 4 0.0026
131 LIP ERYTHEMA 2 0.0025
132 SEPSIS NEONATAL 2 0.0025
133 NECROTISING ENTEROCOLITIS NEONATAL 1 0.0025
134 VIRAL RASH 1 0.0025
135 VACCINATION COMPLICATION 2 0.0024
136 CEREBRAL VENOUS SINUS THROMBOSIS 2 0.0024
137 HYPERFERRITINAEMIA 1 0.0023
138 IMMUNISATION 1 0.0023
139 FOOD REFUSAL 2 0.0023
140 RHONCHI 3 0.0022
141 EXTRA DOSE ADMINISTERED 84 0.0021
142 PLAGIOCEPHALY 1 0.0020
143 POSTURING 1 0.0019
144 INHIBITORY DRUG INTERACTION 3 0.0019
145 BRONCHOSTENOSIS 1 0.0018
146 MILK ALLERGY 1 0.0018
147 APNOEIC ATTACK 1 0.0018
148 ROTAVIRUS INFECTION 1 0.0017
149 HYPORESPONSIVE TO STIMULI 2 0.0017
150 CYTOMEGALOVIRUS TEST POSITIVE 3 0.0017
151 ESCHERICHIA TEST POSITIVE 2 0.0017
152 PUPILLARY DISORDER 1 0.0016
153 OESOPHAGEAL ATRESIA 1 0.0016
154 PLEURAL DISORDER 1 0.0016
155 PLATELET TRANSFUSION 2 0.0016
156 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
157 EXPIRED PRODUCT ADMINISTERED 50 0.0015
158 HYPOTONIA 15 0.0015
159 BRONCHITIS VIRAL 1 0.0015
160 CYANOSIS 23 0.0015
161 DEATH NEONATAL 2 0.0014
162 BREATH SOUNDS ABNORMAL 7 0.0014
163 HYPERPYREXIA 6 0.0014
164 TACHYPNOEA 19 0.0014
165 OTITIS MEDIA ACUTE 1 0.0014
166 PNEUMONIA PNEUMOCOCCAL 2 0.0013
167 PARAINFLUENZAE VIRUS INFECTION 2 0.0013
168 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
169 PRODUCT KNOWLEDGE DEFICIT 1 0.0013
170 PNEUMONIA MYCOPLASMAL 1 0.0013
171 RETICULOCYTE COUNT INCREASED 1 0.0012
172 OTITIS MEDIA 4 0.0012
173 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
174 RALES 7 0.0012
175 RESPIRATORY DISTRESS 33 0.0012
176 PYLORIC STENOSIS 1 0.0012
177 EXPOSURE TO SARS-COV-2 2 0.0012
178 GAZE PALSY 2 0.0012
179 HEPATOSPLENOMEGALY 3 0.0012
180 RESPIRATION ABNORMAL 8 0.0012
181 ENTEROVIRUS INFECTION 1 0.0012
182 UPPER AIRWAY OBSTRUCTION 1 0.0011
183 PARVOVIRUS B19 INFECTION 1 0.0011
184 DRUG MONITORING PROCEDURE NOT PERFORMED 2 0.0011
185 SELECTIVE EATING DISORDER 1 0.0011
186 NASAL OBSTRUCTION 2 0.0011
187 JAUNDICE NEONATAL 2 0.0011
188 ADENOVIRUS INFECTION 3 0.0010
189 SYRINGE ISSUE 18 0.0010
190 INCORRECT DOSE ADMINISTERED 234 0.0010
191 EYELID RASH 1 0.0010
192 DRUG ADMINISTERED IN WRONG DEVICE 1 0.0010
193 STRIDOR 3 0.0010
194 CREPITATIONS 3 0.0010
195 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 17 0.0010
196 FOAMING AT MOUTH 2 0.0010
197 POSTICTAL STATE 1 0.0010
198 PETECHIAE 10 0.0010
199 POOR QUALITY PRODUCT ADMINISTERED 10 0.0009
200 TORTICOLLIS 2 0.0009
201 SCREAMING 6 0.0009
202 CEREBRAL ARTERY OCCLUSION 1 0.0009
203 BLOOD FIBRINOGEN DECREASED 1 0.0009
204 EYE MOVEMENT DISORDER 6 0.0009
205 HAEMANGIOMA 2 0.0009
206 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
207 DYSPLASIA 1 0.0008
208 BRONCHIAL HYPERREACTIVITY 1 0.0008
209 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
210 MUCOUS STOOLS 4 0.0008
211 VENOOCCLUSIVE DISEASE 2 0.0008
212 MENINGITIS 5 0.0007
213 WHEEZING 44 0.0007
214 MENINGITIS VIRAL 1 0.0007
215 BRONCHIAL OBSTRUCTION 1 0.0007
216 OXYGEN SATURATION ABNORMAL 2 0.0007
217 ESCHERICHIA SEPSIS 2 0.0007
218 PRODUCT DISPENSING ERROR 15 0.0007
219 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
220 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
221 IMPETIGO 1 0.0007
222 ORAL MUCOSAL EXFOLIATION 1 0.0007
223 INTELLECTUAL DISABILITY 1 0.0007
224 DYSCHEZIA 2 0.0007
225 ERYTHEMA MULTIFORME 6 0.0006
226 TRANSCRIPTION MEDICATION ERROR 1 0.0006
227 NEONATAL DISORDER 1 0.0006
228 ACUTE RESPIRATORY FAILURE 12 0.0006
229 RESUSCITATION 1 0.0006
230 FLUID INTAKE REDUCED 3 0.0006
231 SEIZURE LIKE PHENOMENA 1 0.0006
232 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
233 AMMONIA INCREASED 3 0.0006
234 MILIARIA 1 0.0006
235 HYPOPNOEA 2 0.0006
236 BLOOD LACTIC ACID INCREASED 3 0.0006
237 CONJUNCTIVAL HYPERAEMIA 2 0.0006
238 LIVER TRANSPLANT REJECTION 1 0.0006
239 NEURODERMATITIS 2 0.0005
240 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
241 PULMONARY HAEMORRHAGE 4 0.0005
242 PYELONEPHRITIS ACUTE 1 0.0005
243 HYPERAEMIA 1 0.0005
244 UNDERWEIGHT 1 0.0005
245 INJECTION SITE VESICLES 3 0.0005
246 HYPERBILIRUBINAEMIA 5 0.0005
247 BODY TEMPERATURE FLUCTUATION 1 0.0005
248 RHINORRHOEA 31 0.0005
249 LUNG ABSCESS 1 0.0005
250 HYPOPHAGIA 12 0.0005
251 INJECTION SITE INDURATION 6 0.0005
252 SPUTUM INCREASED 1 0.0005
253 HYPOXIA 16 0.0005
254 CORNEAL OEDEMA 1 0.0004
255 PALLOR 12 0.0004
256 RESPIRATORY ARREST 12 0.0004
257 PRODUCT STORAGE ERROR 38 0.0004
258 UMBILICAL HERNIA 2 0.0004
259 UNRESPONSIVE TO STIMULI 11 0.0004
260 ESCHERICHIA BACTERAEMIA 1 0.0004
261 STARING 1 0.0004
262 WRONG DOSE 1 0.0004
263 MOUTH HAEMORRHAGE 3 0.0004
264 INCORRECT DOSAGE ADMINISTERED 2 0.0004
265 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
266 COUGH 112 0.0004
267 ERYSIPELAS 2 0.0004
268 HYPOTHERMIA 4 0.0004
269 FEEDING DISORDER 8 0.0004
270 FAILURE TO THRIVE 2 0.0004
271 CRYING 14 0.0004
272 TONSILLITIS 2 0.0004
273 APLASTIC ANAEMIA 2 0.0004
274 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 1 0.0004
275 BRADYPNOEA 1 0.0004
276 ERYTHEMA OF EYELID 2 0.0004
277 EAR CONGESTION 1 0.0004
278 ABNORMAL FAECES 3 0.0004
279 NONSPECIFIC REACTION 2 0.0004
280 MACULE 1 0.0004
281 PROCTITIS 1 0.0004
282 OXYGEN SATURATION DECREASED 20 0.0004
283 ACCIDENTAL OVERDOSE 13 0.0004
284 HYPERTONIA 2 0.0003
285 CARDIAC MURMUR 3 0.0003
286 EYELID MARGIN CRUSTING 1 0.0003
287 RESPIRATORY TRACT INFECTION 9 0.0003
288 GASTROENTERITIS 5 0.0003
289 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
290 PYREXIA 114 0.0003
291 OLIGURIA 2 0.0003
292 SWELLING OF EYELID 2 0.0003
293 ATELECTASIS 3 0.0003
294 POSTURE ABNORMAL 1 0.0003
295 CORONAVIRUS INFECTION 2 0.0003
296 BRAIN INJURY 3 0.0003
297 REGURGITATION 1 0.0003
298 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
299 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
300 PAPULE 2 0.0003
301 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
302 NEONATAL RESPIRATORY DISTRESS SYNDROME 1 0.0003
303 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
304 PRODUCT PRESCRIBING ISSUE 6 0.0003
305 UNDERDOSE 20 0.0003
306 HAEMATOCHEZIA 15 0.0003
307 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
308 SNORING 1 0.0003
309 MATERNAL DRUGS AFFECTING FOETUS 2 0.0003
310 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
311 BRONCHITIS 19 0.0003
312 WOUND SECRETION 1 0.0003
313 RESPIRATORY ACIDOSIS 1 0.0003
314 EXPOSURE VIA BREAST MILK 1 0.0003
315 BLEPHARITIS 1 0.0002
316 RESPIRATORY FAILURE 18 0.0002
317 DRUG INEFFECTIVE 324 0.0002
318 BRADYCARDIA 13 0.0002
319 DEMYELINATION 1 0.0002
320 HYPERAESTHESIA 2 0.0002
321 HYPERURICAEMIA 1 0.0002
322 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
323 CIRCULATORY COLLAPSE 4 0.0002
324 PRODUCT DISPENSING ISSUE 1 0.0002
325 SARS-COV-2 TEST POSITIVE 3 0.0002
326 RESPIRATORY RATE INCREASED 2 0.0002
327 NASAL CONGESTION 13 0.0002
328 C-REACTIVE PROTEIN INCREASED 8 0.0002
329 ACUTE HEPATIC FAILURE 3 0.0002
330 LOCALISED OEDEMA 1 0.0002
331 CONJUNCTIVITIS 4 0.0002
332 DISSEMINATED INTRAVASCULAR COAGULATION 3 0.0002
333 PULSE ABSENT 1 0.0002
334 BRONCHOSPASM 3 0.0002
335 LETHARGY 12 0.0002
336 SINUS BRADYCARDIA 2 0.0002
337 RASH VESICULAR 1 0.0002
338 HEPATOMEGALY 2 0.0002
339 THERAPY CHANGE 2 0.0002
340 INFLAMMATORY MARKER INCREASED 1 0.0002
341 INJECTION SITE INFLAMMATION 1 0.0002
342 APPLICATION SITE SWELLING 1 0.0002
343 RESPIRATORY DISORDER 6 0.0002
344 SALIVARY HYPERSECRETION 2 0.0002
345 PETIT MAL EPILEPSY 1 0.0002
346 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
347 INCREASED UPPER AIRWAY SECRETION 1 0.0002
348 PERIORBITAL OEDEMA 1 0.0002
349 EYE DISCHARGE 2 0.0002
350 PARTIAL SEIZURES 1 0.0002
351 PRODUCTIVE COUGH 9 0.0002
352 NYSTAGMUS 1 0.0002
353 JAUNDICE 5 0.0002
354 BEHAVIOUR DISORDER 1 0.0002
355 NORMAL NEWBORN 1 0.0002
356 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
357 HYDROCEPHALUS 1 0.0002
358 IRRITABILITY 11 0.0002
359 VIRAL INFECTION 6 0.0002
360 COAGULOPATHY 3 0.0002
361 TRANSAMINASES INCREASED 4 0.0002
362 STREPTOCOCCAL INFECTION 1 0.0002
363 RASH PAPULAR 4 0.0002
364 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
365 PREMATURE LABOUR 1 0.0002
366 PERIORBITAL SWELLING 1 0.0002
367 SKIN WARM 1 0.0002
368 VASCULITIS 2 0.0002
369 RASH MACULAR 6 0.0002
370 PRODUCT LABEL CONFUSION 1 0.0002
371 HYPOVOLAEMIA 1 0.0002
372 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
373 PRODUCT PRESCRIBING ERROR 4 0.0002
374 BLEPHAROSPASM 1 0.0002
375 OCCUPATIONAL EXPOSURE TO PRODUCT 1 0.0002
376 URTICARIA 26 0.0002
377 CHOKING 3 0.0002
378 WALKING AID USER 1 0.0002
379 UPPER RESPIRATORY TRACT INFECTION 7 0.0002
380 SOPOR 2 0.0002
381 PRODUCT ADMINISTRATION ERROR 3 0.0001
382 DYSKINESIA 6 0.0001
383 BODY TEMPERATURE INCREASED 3 0.0001
384 ECCHYMOSIS 1 0.0001
385 PERIPHERAL COLDNESS 2 0.0001
386 ENCEPHALITIS 1 0.0001
387 MOUTH ULCERATION 3 0.0001
388 APPLICATION SITE REACTION 1 0.0001
389 LYMPHADENOPATHY 5 0.0001
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
391 EATING DISORDER 3 0.0001
392 MYELOSUPPRESSION 5 0.0001
393 FAECES DISCOLOURED 3 0.0001
394 APATHY 2 0.0001
395 RASH MACULO-PAPULAR 3 0.0001
396 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
397 INJECTION SITE RASH 4 0.0001
398 MUSCLE TWITCHING 3 0.0001
399 SEIZURE 15 0.0001
400 HAEMORRHAGIC STROKE 1 0.0001
401 RESPIRATORY TRACT CONGESTION 2 0.0001
402 BLOOD DISORDER 1 0.0001
403 HICCUPS 1 0.0001
404 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
405 HEPATITIS 3 0.0001
406 ANURIA 1 0.0001
407 MYOPATHY 1 0.0001
408 DEVICE DEFECTIVE 2 0.0001
409 PRODUCT COMMUNICATION ISSUE 1 0.0001
410 LUNG INFILTRATION 1 0.0001
411 PURPURA 1 0.0001
412 EAR INFECTION 3 0.0001
413 MYOSITIS 1 0.0001
414 FREQUENT BOWEL MOVEMENTS 3 0.0001
415 LEUKOCYTOSIS 2 0.0001
416 PATHOGEN RESISTANCE 1 0.0001
417 PNEUMONIA BACTERIAL 1 0.0001
418 INCREASED TENDENCY TO BRUISE 1 0.0001
419 PRODUCT PACKAGING ISSUE 1 0.0001
420 FEELING JITTERY 2 0.0001
421 RASH ERYTHEMATOUS 5 0.0001
422 PRESCRIBED OVERDOSE 2 0.0001
423 ASCITES 3 0.0001
424 PRESCRIBED UNDERDOSE 2 0.0001
425 LACRIMATION INCREASED 3 0.0001
426 TOXIC SKIN ERUPTION 1 0.0001
427 MOTOR DYSFUNCTION 1 0.0001
428 INJECTION SITE WARMTH 2 0.0001
429 CARDIAC ARREST 8 0.0001
430 EXPOSURE DURING PREGNANCY 6 0.0001
431 CARDIO-RESPIRATORY ARREST 4 0.0001
432 SUDDEN DEATH 1 0.0001
433 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
434 METABOLIC ACIDOSIS 3 0.0001
435 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
436 INJECTION SITE NODULE 1 0.0001
437 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
438 INFLUENZA 10 0.0001
439 RASH 39 0.0001
440 SKIN INFECTION 1 0.0001
441 STATUS EPILEPTICUS 1 0.0001
442 SKIN DISCOLOURATION 4 0.0001
443 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
444 SWELLING 8 0.0001
445 PRODUCT USE ISSUE 16 0.0001
446 MYOCLONUS 1 0.0001
447 MUSCLE RIGIDITY 1 0.0001
448 RESPIRATORY DEPRESSION 1 0.0001
449 NASOPHARYNGITIS 15 0.0001
450 DYSPNOEA 46 0.0001
451 GENERALISED OEDEMA 1 0.0001
452 PHARYNGITIS 1 0.0001
453 THROMBOCYTOPENIA 9 0.0001
454 SECRETION DISCHARGE 1 0.0001
455 HAEMATEMESIS 2 0.0001
456 HEPATIC CYTOLYSIS 1 0.0001
457 DECREASED APPETITE 18 0.0001
458 EXPOSURE VIA SKIN CONTACT 2 0.0001
459 NODULE 1 0.0001
460 MUCOSAL INFLAMMATION 2 0.0001
461 ORAL CANDIDIASIS 1 0.0001
462 PULMONARY CONGESTION 1 0.0001
463 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
464 OVERDOSE 16 0.0001
465 MASS 1 0.0001
466 SKIN REACTION 1 0.0001
467 ASTHMA 8 0.0001
468 LYMPHOPENIA 1 0.0001
469 FLATULENCE 4 0.0001
470 DIALYSIS 1 0.0001
471 SUBDURAL HAEMATOMA 1 0.0001
472 HYPERSOMNIA 2 0.0001
473 IMPAIRED QUALITY OF LIFE 1 0.0001
474 SOMNOLENCE 14 0.0001
475 HYPOKINESIA 1 0.0001
476 NEEDLE ISSUE 2 0.0001
477 PNEUMONIA 22 0.0001
478 ILLNESS 7 0.0001
479 ANGIOEDEMA 3 0.0001
480 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
481 HAEMORRHAGE INTRACRANIAL 1 0.0001
482 THERAPEUTIC RESPONSE DECREASED 4 0.0001
483 INJECTION SITE SWELLING 5 0.0001
484 FEELING HOT 4 0.0001
485 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
486 ULCER 1 0.0001
487 BLOOD GLUCOSE DECREASED 3 0.0001
488 LIP SWELLING 2 0.0001
489 LEUKOPENIA 3 0.0001
490 VOMITING 28 0.0001
491 INJECTION SITE REACTION 4 0.0001
492 ANAEMIA 11 0.0001
493 ECZEMA 3 0.0001
494 DEVICE USE ISSUE 1 0.0001
495 MUSCULOSKELETAL STIFFNESS 5 0.0001
496 EOSINOPHILIA 1 0.0001
497 COVID-19 10 0.0001
498 SLEEP DISORDER 4 0.0001
499 GASTROENTERITIS VIRAL 1 0.0001
500 OEDEMA 3 0.0001
501 OSTEOMYELITIS 1 0.0001
502 HEPATIC FUNCTION ABNORMAL 2 0.0001
503 ERYTHEMA 11 0.0001
504 INCREASED APPETITE 1 0.0001
505 POST PROCEDURAL COMPLICATION 1 0.0001
506 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
507 HAEMATOCRIT DECREASED 1 0.0001
508 PRODUCT PHYSICAL ISSUE 1 0.0000
509 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
510 INJURY ASSOCIATED WITH DEVICE 1 0.0000
511 PRODUCT PREPARATION ERROR 1 0.0000
512 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
513 INFECTION 7 0.0000
514 TREATMENT FAILURE 4 0.0000
515 RECTAL HAEMORRHAGE 2 0.0000
516 FEBRILE NEUTROPENIA 3 0.0000
517 TACHYCARDIA 4 0.0000
518 PULMONARY OEDEMA 2 0.0000
519 GASTROINTESTINAL DISORDER 4 0.0000
520 SNEEZING 1 0.0000
521 NEUTROPENIA 6 0.0000
522 PERICARDIAL EFFUSION 1 0.0000
523 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
524 OCULAR HYPERAEMIA 2 0.0000
525 LOCALISED INFECTION 1 0.0000
526 MENTAL IMPAIRMENT 1 0.0000
527 PRESYNCOPE 1 0.0000
528 INJECTION SITE URTICARIA 1 0.0000
529 INJECTION SITE ERYTHEMA 5 0.0000
530 EXTRAPYRAMIDAL DISORDER 1 0.0000
531 LOSS OF CONSCIOUSNESS 5 0.0000
532 NO ADVERSE EVENT 7 0.0000
533 APPLICATION SITE ERYTHEMA 1 0.0000
534 INCORRECT DOSE ADMINISTERED BY DEVICE 1 0.0000
535 DERMATITIS ATOPIC 2 0.0000
536 BLOOD BILIRUBIN INCREASED 1 0.0000
537 SKIN LESION 1 0.0000
538 CONDITION AGGRAVATED 11 0.0000
539 PRODUCT SUBSTITUTION ISSUE 2 0.0000
540 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
541 CHILLS 4 0.0000
542 DEVICE ISSUE 3 0.0000
543 PREMATURE BABY 1 0.0000
544 HEPATIC FAILURE 1 0.0000
545 PLEURAL EFFUSION 2 0.0000
546 DISCOMFORT 2 0.0000
547 EPILEPSY 1 0.0000
548 NERVOUS SYSTEM DISORDER 1 0.0000
549 SWOLLEN TONGUE 1 0.0000
550 HYPOTHYROIDISM 1 0.0000
551 MOVEMENT DISORDER 1 0.0000
552 DIARRHOEA 20 0.0000
553 SWELLING FACE 2 0.0000
554 STAPHYLOCOCCAL INFECTION 1 0.0000
555 DEHYDRATION 4 0.0000
556 ABDOMINAL DISTENSION 3 0.0000
557 HEART RATE DECREASED 1 0.0000
558 CEREBRAL HAEMORRHAGE 1 0.0000
559 HYPERGLYCAEMIA 1 0.0000
560 AGITATION 2 0.0000
561 SEPSIS 3 0.0000
562 EYE SWELLING 1 0.0000
563 EPISTAXIS 2 0.0000
564 COLITIS 1 0.0000
565 CARDIAC FAILURE 2 0.0000
566 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
567 INFLUENZA LIKE ILLNESS 2 0.0000
568 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
569 DEVICE LEAKAGE 1 0.0000
570 DEVICE DISLOCATION 1 0.0000
571 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
572 THERAPY NON-RESPONDER 1 0.0000
573 ADVERSE EVENT 2 0.0000
574 HYPERSENSITIVITY 4 0.0000
575 ARRHYTHMIA 1 0.0000
576 DYSPHAGIA 2 0.0000
577 FEELING ABNORMAL 5 0.0000
578 INTERSTITIAL LUNG DISEASE 1 0.0000
579 HYPOGLYCAEMIA 1 0.0000
580 LUNG DISORDER 1 0.0000
581 FLUSHING 2 0.0000
582 DEPRESSED MOOD 1 0.0000
583 DRUG INTERACTION 3 0.0000
584 RASH PRURITIC 1 0.0000
585 ANAPHYLACTIC REACTION 1 0.0000
586 TREMOR 3 0.0000
587 FATIGUE 14 0.0000
588 BLISTER 1 0.0000
589 HYPONATRAEMIA 1 0.0000
590 DYSPHONIA 1 0.0000
591 OEDEMA PERIPHERAL 2 0.0000
592 ASTHENIA 6 0.0000
593 BLOOD PRESSURE DECREASED 1 0.0000
594 INSOMNIA 4 0.0000
595 HYPOTENSION 3 0.0000
596 OFF LABEL USE 13 0.0000
597 HEPATIC ENZYME INCREASED 1 0.0000
598 DEVICE MALFUNCTION 1 0.0000
599 THERAPY INTERRUPTED 1 0.0000
600 DEATH 12 0.0000
601 MALAISE 6 0.0000
602 CHRONIC KIDNEY DISEASE 1 0.0000
603 ACUTE KIDNEY INJURY 2 0.0000
604 INJECTION SITE PAIN 4 0.0000
605 HOSPITALISATION 2 0.0000
606 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
607 RENAL IMPAIRMENT 1 0.0000
608 SKIN EXFOLIATION 1 0.0000
609 URINARY TRACT INFECTION 2 0.0000
610 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
611 WEIGHT DECREASED 3 0.0000
612 CARDIAC DISORDER 1 0.0000
613 PULMONARY EMBOLISM 1 0.0000
614 CONTUSION 1 0.0000
615 HEART RATE INCREASED 1 0.0000
616 SYNCOPE 1 0.0000
617 HAEMOGLOBIN DECREASED 1 0.0000
618 HAEMORRHAGE 1 0.0000
619 PLATELET COUNT DECREASED 1 0.0000
620 CONSTIPATION 2 0.0000
621 RENAL FAILURE 1 0.0000
622 DRY SKIN 1 0.0000
623 CEREBROVASCULAR ACCIDENT 1 0.0000
624 ABDOMINAL PAIN 1 0.0000
625 ANXIETY 1 0.0000
626 PAIN IN EXTREMITY 1 0.0000
627 DIZZINESS 1 0.0000